Biorelate
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $10M
Investors
- 5
About Biorelate
Based in the UK, Biorelate Ltd.Biorelate Ltd. is a biopharmaceutical data curation company founded in 2014 by Daniel Jamieson, who serves as the CEO. The company is headquartered in Manchester, UK.Biorelate specializes in advanced data curation technologies within the biopharmaceutical sector, primarily through its flagship platform, Galactic AI™. This innovative product utilizes sophisticated algorithms and natural language processing to analyze extensive biomedical literature, including journals, patents, and clinical trials, to identify and curate relevant cause-and-effect relationships among drugs, genes, and diseases. By streamlining the data curation process, Galactic AI™ aims to accelerate drug discovery and target validation for researchers, data scientists, and biopharmaceutical professionals. Key clients include globally recognized pharmaceutical companies such as Pfizer and AstraZeneca, alongside dynamic biotech firms, which utilize Biorelate's services for innovative drug target selection and biomarker identification.Biorelate generates revenue primarily through a subscription-based model for its Galactic AI™ platform and related services. Clients typically engage in annual or multi-year contracts, granting access to the platform's data curation capabilities and analytical tools tailored to their specific research needs. The transactions often involve partnerships with large pharmaceutical companies and biotech firms, which leverage Galactic AI™ for efficient drug target identification and evidence-based decision-making in scientific research.In November 2022, Biorelate Ltd. The company plans to utilize these funds to expand its commercial and technical teams, with a specific focus on growth in the US market. Future developments include potential new products and services aimed at enhancing their data curation capabilities, although specific product launches and release dates have not been disclosed.
Who invested in Biorelate
5 investors across 2 rounds
See all investors in Biorelate
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biorelate
Who invested in Biorelate?
Biorelate has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biorelate raised?
Biorelate has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biorelate last raise money?
Biorelate's most recent round on record is a Series A, in Nov 2022.
What does Biorelate do?
Based in the UK, Biorelate Ltd.
Where is Biorelate headquartered?
Biorelate is headquartered in Manchester, UK.
Which VCs invest in companies like Biorelate?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back healthcare it companies at Biorelate's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Biorelate? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.